Professional
Added to YB: 2024-05-21
Pitch date: 2024-03-31
PFE [bullish]
Pfizer Inc.
+4.39%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$146.5B
Pitch Price
$24.76
Price Target
N/A
Dividend
6.67%
EV/EBITDA
7.56
P/E
14.98
EV/Sales
3.09
Sector
Pharmaceuticals
Category
value
Show full summary:
Diamond Hill Select Fund New Portfolio Holding: Pfizer Inc.
PFE: COVID windfall fueled M&A but margins & profits down as sales waned. Cost cuts aim to boost margins as base biz stays strong. Initiated position on attractive valuation given outlook. Sees depressed price as opportunity with strong non-COVID portfolio & margin expansion plan.
Read full article (1 min)